In head and neck cancer (HNC) there is a need for more personalized treatment based on
risk assessment for treatment related adverse events (ie toxicities and complications) …

Sarcopenia is an increasingly recognized biomarker associated with poorer outcomes. The
objective of this study was to ascertain the effect of sarcopenia on treatment tolerance and …

Background Frailty has been shown to adversely impact outcomes in a number of surgical
disciplines. In head and neck reconstructive surgery, frailty may represent a significant risk …

Objective Sarcopenia, characterized by decreased skeletal muscle mass, is associated with
poorer oncologic outcomes in head and neck cancer (HNC) patients. The effect of …

Lenvatinib (LEN) is a multi-target TKI, which plays a pivotal role in the treatment of advanced
hepatocellular carcinoma (HCC). The inevitable occurrence of drug resistance still prevents …

Introduction Frailty is a recognized condition associated with poorer outcomes in patients
with head and neck cancer (HNC). The objective of this study was to ascertain the …

Purpose We performed this systematic review and meta-analysis to explore the impact of
preoperative sarcopenia on postoperative complication risks after head and neck cancer …

Background Identifying at‐risk patients for complications remains challenging in patients
with chronic lower extremity (LE) wounds receiving free tissue transfer (FTT) for limb …

Sarcopenia is a disease in which a decline in muscle mass with age is associated with a
decline in physical performance. In the field of otorhinolaryngology, head and neck surgery …

Background: The association between pretreatment skeletal muscle index (SMI) and long-
term survival of pancreatic carcinoma patients remains unclear up to now. Methods: The …